Industrial Gases & Fuels · Founded 1935 · BSE 523457 · NSE LINDEINDIA · ISIN INE473A01011
No Notes Added Yet
Business
Linde India Ltd. is a leading industrial gases and engineering company in India. Its core business involves the manufacturing, supply, and distribution of industrial, medical, and specialty gases, including oxygen, nitrogen, argon, hydrogen, and helium. The company also offers a range of related services such as installation of gas plants and equipment, gas management solutions, and cylinder filling. It operates through on-site plants, pipelines, and bulk and packaged gas delivery. Linde India serves a diverse set of industries including metals, healthcare, chemicals, electronics, automotive, food & beverage, and pharmaceuticals. Revenue is primarily generated from gas sales (long-term contracts, bulk, packaged) and through its Project Engineering Division (PED) which designs, engineers, and installs air separation units (ASUs) and other gas plants.
Revenue Mix
Linde India Ltd. primarily operates in two main segments:
Gases Business: This segment involves the production and distribution of various industrial, medical, and specialty gases. It typically accounts for the majority of the company's revenue and profits. Supply modes include on-site plants (often integrated into customer facilities via pipelines), bulk deliveries (cryogenic tankers), and packaged gases (cylinders).
Project Engineering Division (PED): This segment provides engineering, procurement, and construction (EPC) services for air separation units (ASUs) and other gas processing plants for both internal use and third-party clients. While it can contribute significantly to revenue, its contribution can be more volatile due to the project-based nature.
Specific revenue contributions for the latest periods would require checking the company's financial reports, but the Gases business generally forms the larger and more stable portion.
Industry
The industrial gases industry in India is characterized by high capital intensity, technological complexity, and strict safety regulations, leading to high barriers to entry. It's largely an oligopolistic market dominated by a few global players. Linde India, being part of Linde plc (a global leader in industrial gases), holds a strong market position in India. Its global parentage provides access to advanced technology, operational expertise, and capital. Key competitors in India include Air Liquide India and some smaller domestic players. Linde India is generally considered one of the top two players in the Indian market, particularly in high-purity and specialty gases.
MOAT
Linde India possesses several durable competitive advantages:
Scale and Network Effect: Extensive production and distribution network across India, including on-site plants and pipeline infrastructure, making it costly and time-consuming for new entrants to replicate.
High Switching Costs: Customers, especially large industrial clients, integrate gas supply into their core production processes (e.g., steel manufacturing, chemical plants). The disruption and cost associated with switching suppliers, dismantling existing infrastructure, and building new connections are very high, leading to long-term contracts (10-20 years).
Technological Leadership & Global Parentage: As a subsidiary of Linde plc, it benefits from world-class R&D, advanced process technology, engineering expertise, and global procurement advantages.
Capital Intensity: The significant upfront capital investment required for Air Separation Units (ASUs) and cryogenic storage/transport infrastructure acts as a formidable barrier to entry.
Safety & Reliability: The industry demands stringent safety standards and highly reliable supply, which large established players like Linde are best equipped to provide, building trust and long-term relationships.
Growth Drivers
Industrialization & Manufacturing Growth: India's focus on "Make in India" and infrastructure development (steel, cement) directly drives demand for industrial gases.
Healthcare Sector Expansion: Increasing healthcare infrastructure and demand for medical oxygen and other gases in hospitals.
Emerging Industries: Growth in sectors like electronics, specialty chemicals, renewable energy (e.g., green hydrogen applications), and advanced manufacturing will fuel demand for high-purity and specialty gases.
Economic Expansion: Overall GDP growth in India is strongly correlated with increased industrial output and consequently, demand for industrial gases.
Clean Energy Transition: Growing interest in hydrogen as a clean fuel and other related applications.
Risks
Economic Slowdown: A downturn in key end-user industries (e.g., steel, automotive, chemicals) can directly reduce demand for industrial gases.
Energy Price Volatility: Power is a significant input cost for Air Separation Units (ASUs). Fluctuations in electricity prices can impact profitability.
Intense Competition & Pricing Pressure: Despite the oligopolistic nature, competition among major players for large industrial contracts can lead to pricing pressures.
Project Execution Risk: The Project Engineering Division faces risks associated with large, complex projects, including delays, cost overruns, and technological challenges.
Regulatory Changes: Evolving environmental and safety regulations could require additional investments or impact operational costs.
Capital Intensity: The business requires continuous significant capital expenditure to expand capacity and maintain infrastructure, which could strain finances during periods of low demand or high interest rates.
Management & Ownership
Linde India Ltd. is a publicly listed company in India, but it is majority-owned and controlled by Linde plc, a global leader in industrial gases and engineering. Linde plc serves as the ultimate promoter. The management team typically comprises experienced professionals, often with global exposure through the parent company. Given its affiliation with a global multinational corporation, the company generally adheres to high standards of corporate governance, operational excellence, and technical expertise. The ownership structure reflects a strong strategic alignment with the global parent's vision and technological prowess.
Outlook
Linde India is well-positioned to benefit from India's long-term industrialization trend and economic growth. Its strong competitive advantages, backed by global parent Linde plc's technology and capital, provide a durable moat in the high-barrier-to-entry industrial gas market. The increasing demand from core sectors like manufacturing, healthcare, and emerging areas like electronics and clean energy should drive steady growth. However, the company's performance remains cyclical, closely tied to the health of the broader industrial economy, and is susceptible to fluctuations in energy costs and competitive intensity in securing new long-term contracts. While capital-intensive, its established infrastructure and market leadership provide a stable foundation for continued expansion aligned with India's economic trajectory.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 706 | 630 | 653 | 634 | 606 | 592 | 571 | 644 | 701 | 614 |
| Other Income | 22 | 18 | 19 | 16 | 19 | 13 | 4 | 4 | 4 | 6 |
| Total Income | 728 | 648 | 672 | 651 | 625 | 605 | 575 | 648 | 705 | 620 |
| Total Expenditure | 520 | 452 | 469 | 456 | 414 | 382 | 374 | 362 | 444 | 441 |
| Operating Profit | 208 | 197 | 203 | 195 | 211 | 223 | 201 | 286 | 261 | 179 |
| Interest | 1 | 4 | 2 | 2 | 2 | 7 | 3 | 3 | 6 | 3 |
| Depreciation | 51 | 52 | 51 | 52 | 55 | 56 | 56 | 56 | 62 | 61 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 156 | 141 | 150 | 141 | 155 | 161 | 142 | 226 | 194 | 115 |
| Provision for Tax | 39 | 37 | 38 | 37 | 41 | 43 | 37 | 57 | 52 | 39 |
| Profit After Tax | 117 | 104 | 112 | 104 | 114 | 118 | 105 | 169 | 143 | 77 |
| Adjustments | 3 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 51 | 1 |
| Profit After Adjustments | 120 | 105 | 114 | 106 | 116 | 118 | 107 | 171 | 193 | 77 |
| Adjusted Earnings Per Share | 14.1 | 12.4 | 13.3 | 12.5 | 13.6 | 13.9 | 12.6 | 20.1 | 22.7 | 9.1 |
| #(Fig in Cr.) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1825 | 2033 | 2192 | 1762 | 1471 | 2112 | 3136 | 2769 | 2485 | 2530 |
| Other Income | 31 | 8 | 9 | 22 | 33 | 56 | 105 | 83 | 72 | 18 |
| Total Income | 1857 | 2041 | 2201 | 1783 | 1504 | 2167 | 3241 | 2851 | 2557 | 2548 |
| Total Expenditure | 1539 | 1710 | 1866 | 1348 | 1096 | 1566 | 2372 | 2072 | 1724 | 1621 |
| Operating Profit | 318 | 331 | 335 | 436 | 407 | 601 | 869 | 779 | 833 | 927 |
| Interest | 116 | 116 | 103 | 86 | 6 | 3 | 6 | 7 | 13 | 15 |
| Depreciation | 195 | 202 | 199 | 177 | 176 | 181 | 253 | 201 | 214 | 235 |
| Exceptional Income / Expenses | 0 | -6 | 0 | 841 | 2 | 275 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 16 | 13 | 39 | 1013 | 229 | 698 | 618 | 579 | 614 | 677 |
| Provision for Tax | -3 | -3 | 14 | 286 | 78 | 191 | 80 | 145 | 159 | 185 |
| Profit After Tax | 19 | 16 | 26 | 727 | 151 | 507 | 538 | 434 | 455 | 494 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 56 |
| Profit After Adjustments | 19 | 16 | 26 | 727 | 151 | 507 | 538 | 434 | 455 | 548 |
| Adjusted Earnings Per Share | 2.2 | 1.9 | 3 | 85.3 | 17.7 | 59.5 | 63.1 | 50.9 | 53.3 | 64.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -10% | 6% | 7% | 0% |
| Operating Profit CAGR | 7% | 11% | 14% | 0% |
| PAT CAGR | 5% | -4% | -9% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -7% | 21% | 34% | 38% |
| ROE Average | 12% | 15% | 14% | 13% |
| ROCE Average | 17% | 19% | 19% | 17% |
| #(Fig in Cr.) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1441 | 1451 | 1462 | 2172 | 2234 | 2715 | 3140 | 3468 | 3820 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 990 | 776 | 417 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 164 | 165 | 178 | 294 | 342 | 933 | 870 | 842 | 1038 |
| Total Current Liabilities | 1013 | 1020 | 1364 | 784 | 710 | 875 | 1066 | 1327 | 1315 |
| Total Liabilities | 3608 | 3412 | 3420 | 3250 | 3286 | 4523 | 5077 | 5637 | 6173 |
| Fixed Assets | 2573 | 2498 | 2162 | 2035 | 1989 | 1869 | 1762 | 1822 | 1925 |
| Other Non-Current Assets | 266 | 240 | 218 | 258 | 211 | 787 | 1116 | 1585 | 2965 |
| Total Current Assets | 769 | 675 | 765 | 902 | 1041 | 1845 | 2181 | 2214 | 1266 |
| Total Assets | 3608 | 3412 | 3420 | 3250 | 3286 | 4523 | 5077 | 5637 | 6173 |
| #(Fig in Cr.) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 21 | 106 | 37 | 125 | 240 | 324 | 983 | 1187 | 979 |
| Cash Flow from Operating Activities | 293 | 252 | 376 | 327 | 339 | 589 | 629 | 440 | 584 |
| Cash Flow from Investing Activities | -128 | -59 | -73 | 981 | -54 | 98 | -306 | -539 | -1305 |
| Cash Flow from Financing Activities | -80 | -261 | -216 | -1193 | -201 | -28 | -119 | -109 | -112 |
| Net Cash Inflow / Outflow | 85 | -68 | 87 | 115 | 84 | 659 | 203 | -208 | -833 |
| Closing Cash & Cash Equivalent | 106 | 37 | 125 | 240 | 324 | 983 | 1187 | 979 | 145 |
| # | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.23 | 1.9 | 3.01 | 85.27 | 17.72 | 59.47 | 63.09 | 50.9 | 53.33 |
| CEPS(Rs) | 25.14 | 25.58 | 26.36 | 106.05 | 38.35 | 80.74 | 92.74 | 74.46 | 78.41 |
| DPS(Rs) | 0.75 | 1 | 1.5 | 10 | 3 | 13.5 | 12 | 12 | 12 |
| Book NAV/Share(Rs) | 168.96 | 170.09 | 171.41 | 254.67 | 261.98 | 318.33 | 368 | 406.5 | 447.65 |
| Core EBITDA Margin(%) | 14.49 | 15.29 | 14.84 | 23.51 | 25.48 | 25.84 | 24.35 | 25.17 | 30.64 |
| EBIT Margin(%) | 6.64 | 6.14 | 6.48 | 62.39 | 15.97 | 33.19 | 19.92 | 21.17 | 25.19 |
| Pre Tax Margin(%) | 0.8 | 0.63 | 1.8 | 57.49 | 15.54 | 33.05 | 19.72 | 20.91 | 24.68 |
| PAT Margin (%) | 0.96 | 0.77 | 1.17 | 41.28 | 10.27 | 24.02 | 17.16 | 15.68 | 18.3 |
| Cash Profit Margin (%) | 10.83 | 10.31 | 10.26 | 51.34 | 22.23 | 32.6 | 25.22 | 22.94 | 26.9 |
| ROA(%) | 0.53 | 0.46 | 0.75 | 21.81 | 4.62 | 12.99 | 11.21 | 8.1 | 7.7 |
| ROE(%) | 1.32 | 1.12 | 1.76 | 40.02 | 6.86 | 20.5 | 18.38 | 13.14 | 12.49 |
| ROCE(%) | 4.55 | 4.62 | 5.27 | 44.49 | 10.41 | 28.33 | 21.33 | 17.74 | 17.18 |
| Receivable days | 65.8 | 61.23 | 59.74 | 77.43 | 98.01 | 71.76 | 47.99 | 58.17 | 63.58 |
| Inventory Days | 12.67 | 11.82 | 11.6 | 14.13 | 16.62 | 11.9 | 8.53 | 10.71 | 14.08 |
| Payable days | 446.54 | 375.72 | 267.84 | 300.78 | 435.88 | 276.09 | 163.33 | 218.65 | 375.46 |
| PER(x) | 158.97 | 281.08 | 226.26 | 7.77 | 54.83 | 41.88 | 63.9 | 125.91 | 117.2 |
| Price/Book(x) | 2.1 | 3.14 | 3.98 | 2.6 | 3.71 | 7.82 | 10.95 | 15.77 | 13.96 |
| Dividend Yield(%) | 0.21 | 0.19 | 0.22 | 1.51 | 0.31 | 0.54 | 0.3 | 0.19 | 0.19 |
| EV/Net Sales(x) | 2.39 | 2.85 | 3.14 | 3.13 | 5.41 | 9.59 | 10.59 | 19.39 | 21.39 |
| EV/Core EBITDA(x) | 13.71 | 17.5 | 20.57 | 12.66 | 19.53 | 33.69 | 38.2 | 68.87 | 63.82 |
| Net Sales Growth(%) | 0 | 11.38 | 7.8 | -19.61 | -16.5 | 43.56 | 48.47 | -11.7 | -10.23 |
| EBIT Growth(%) | 0 | -1.15 | 9.39 | 673.63 | -78.63 | 198.41 | -10.9 | -6.15 | 6.82 |
| PAT Growth(%) | 0 | -14.85 | 58.7 | 2730.37 | -79.22 | 235.69 | 6.08 | -19.32 | 4.78 |
| EPS Growth(%) | 0 | -14.85 | 58.7 | 2730.39 | -79.22 | 235.69 | 6.08 | -19.32 | 4.78 |
| Debt/Equity(x) | 1 | 0.88 | 0.82 | 0.05 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 0.76 | 0.66 | 0.56 | 1.15 | 1.47 | 2.11 | 2.05 | 1.67 | 0.96 |
| Quick Ratio(x) | 0.69 | 0.59 | 0.51 | 1.07 | 1.37 | 2.03 | 1.97 | 1.6 | 0.88 |
| Interest Cover(x) | 1.14 | 1.12 | 1.38 | 12.74 | 37.63 | 229.52 | 99.3 | 80.64 | 49.58 |
| Total Debt/Mcap(x) | 0.48 | 0.28 | 0.21 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 2.24 | 2.32 | 3.03 | 2.41 | 2.27 | 2.63 | 2.51 | 2.35 | 2.04 | 2.05 |
| DII | 7.22 | 7.45 | 6.83 | 6.89 | 6.81 | 6.48 | 6.62 | 6.75 | 6.94 | 6.88 |
| Public | 15.53 | 15.24 | 15.14 | 15.7 | 15.93 | 15.89 | 15.87 | 15.9 | 16.02 | 16.07 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 |
| FII | 0.19 | 0.2 | 0.26 | 0.21 | 0.19 | 0.22 | 0.21 | 0.2 | 0.17 | 0.17 |
| DII | 0.62 | 0.63 | 0.58 | 0.59 | 0.58 | 0.55 | 0.56 | 0.58 | 0.59 | 0.59 |
| Public | 1.32 | 1.3 | 1.29 | 1.34 | 1.36 | 1.36 | 1.35 | 1.36 | 1.37 | 1.37 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -10% | +6% | +7% | — |
| Operating Profit CAGR | +7% | +11% | +14% | — |
| PAT CAGR | +5% | -4% | -9% | — |
| Share Price CAGR | -7% | +21% | +34% | +38% |
| ROE Average | +12% | +15% | +14% | +13% |
| ROCE Average | +17% | +19% | +19% | +17% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 2.24 | 2.32 | 3.03 | 2.41 | 2.27 | 2.63 | 2.51 | 2.35 | 2.04 | 2.05 |
| DII | 7.22 | 7.45 | 6.83 | 6.89 | 6.81 | 6.48 | 6.62 | 6.75 | 6.94 | 6.88 |
| Public | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 |
| FII | 0.19 | 0.2 | 0.26 | 0.21 | 0.19 | 0.22 | 0.21 | 0.2 | 0.17 | 0.17 |
| DII | 0.62 | 0.63 | 0.58 | 0.59 | 0.58 | 0.55 | 0.56 | 0.58 | 0.59 | 0.59 |
| Public | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.